GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (OCSE:COLO B) » Definitions » Cyclically Adjusted PB Ratio

Coloplast AS (OCSE:COLO B) Cyclically Adjusted PB Ratio : 15.20 (As of Jul. 15, 2025)


View and export this data going back to 1993. Start your Free Trial

What is Coloplast AS Cyclically Adjusted PB Ratio?

As of today (2025-07-15), Coloplast AS's current share price is kr601.40. Coloplast AS's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was kr39.57. Coloplast AS's Cyclically Adjusted PB Ratio for today is 15.20.

The historical rank and industry rank for Coloplast AS's Cyclically Adjusted PB Ratio or its related term are showing as below:

OCSE:COLO B' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 15.17   Med: 26.76   Max: 43.12
Current: 15.17

During the past years, Coloplast AS's highest Cyclically Adjusted PB Ratio was 43.12. The lowest was 15.17. And the median was 26.76.

OCSE:COLO B's Cyclically Adjusted PB Ratio is ranked worse than
96.79% of 498 companies
in the Medical Devices & Instruments industry
Industry Median: 1.865 vs OCSE:COLO B: 15.17

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Coloplast AS's adjusted book value per share data for the three months ended in Mar. 2025 was kr75.175. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr39.57 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Coloplast AS Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Coloplast AS's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast AS Cyclically Adjusted PB Ratio Chart

Coloplast AS Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.39 35.32 24.27 22.77 23.49

Coloplast AS Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.70 23.23 23.49 20.59 18.28

Competitive Comparison of Coloplast AS's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, Coloplast AS's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast AS's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Coloplast AS's Cyclically Adjusted PB Ratio falls into.


;
;

Coloplast AS Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Coloplast AS's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=601.40/39.57
=15.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coloplast AS's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Coloplast AS's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=75.175/120.2000*120.2000
=75.175

Current CPI (Mar. 2025) = 120.2000.

Coloplast AS Quarterly Data

Book Value per Share CPI Adj_Book
201506 27.409 100.300 32.847
201509 22.266 100.200 26.710
201512 19.049 99.800 22.943
201603 23.164 100.200 27.788
201606 21.248 100.600 25.388
201609 23.935 100.200 28.712
201612 19.851 100.300 23.790
201703 23.870 101.200 28.352
201706 23.343 101.200 27.726
201709 28.050 101.800 33.120
201712 22.176 101.300 26.313
201803 25.351 101.700 29.963
201806 24.554 102.300 28.850
201809 30.221 102.400 35.474
201812 24.434 102.100 28.766
201903 29.055 102.900 33.940
201906 28.002 102.900 32.710
201909 32.544 102.900 38.015
201912 25.620 102.900 29.927
202003 30.963 103.300 36.029
202006 29.909 103.200 34.836
202009 34.822 103.500 40.441
202012 27.094 103.400 31.496
202103 32.572 104.300 37.537
202106 32.557 105.000 37.270
202109 38.383 105.800 43.607
202112 30.162 106.600 34.010
202203 34.778 109.900 38.037
202206 34.266 113.600 36.257
202209 39.057 116.400 40.332
202212 27.813 115.900 28.845
202303 31.331 117.300 32.106
202306 28.908 116.400 29.852
202309 77.001 117.400 78.837
202312 67.275 116.700 69.293
202403 71.987 118.400 73.081
202406 73.427 118.500 74.480
202409 79.624 118.900 80.495
202412 68.604 118.900 69.354
202503 75.175 120.200 75.175

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Coloplast AS  (OCSE:COLO B) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Coloplast AS Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Coloplast AS's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast AS Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

No Headlines